Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.945 | 50 | 1 | 1991 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.690 | None | 0.929 | 9 | 0 | 1997 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.660 | None | 1.000 | 6 | 0 | 1993 | 2017 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.600 | None | 1.000 | 17 | 0 | 1985 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
group | 0.580 | None | 1.000 | 8 | 0 | 2003 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.550 | None | 1.000 | 5 | 0 | 2006 | 2016 | ||||||||
|
glycine N-methyltransferase | 0.626 | 0.462 | 2.8E-03 |
|
group | 0.550 | None | 1.000 | 4 | 0 | 2007 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.540 | None | 1.000 | 4 | 0 | 1997 | 2016 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
group | 0.540 | None | 1.000 | 4 | 0 | 1990 | 2016 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
group | 0.530 | None | 1.000 | 3 | 0 | 1995 | 2001 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
group | 0.520 | None | 1.000 | 2 | 0 | 2000 | 2018 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2009 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 31 | 0 | 1998 | 2020 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 18 | 0 | 1994 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 15 | 0 | 1994 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.400 | None | 1.000 | 15 | 0 | 1990 | 2019 | ||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
group | 0.400 | None | 1.000 | 15 | 0 | 2007 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
group | 0.400 | None | 0.909 | 10 | 0 | 2002 | 2017 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 9 | 0 | 1994 | 2019 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
group | 0.380 | None | 1.000 | 8 | 0 | 2014 | 2019 | ||||||||
|
gap junction protein beta 1 | 0.514 | 0.731 | 0.85 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 1989 | 2016 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 1987 | 2007 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 2004 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.360 | None | 1.000 | 6 | 0 | 2001 | 2007 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.360 | None | 1.000 | 6 | 0 | 1995 | 2017 |